Akèy › Glomeruloskleroz fokal segmantè › Ohio › Cleveland
Etid klinik pou Glomeruloskleroz fokal segmantè nan Cleveland, OH
4 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Ap rekriteFaz 2
- Investigator Site #20, Cleveland
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Ap rekriteFaz 2
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
Nephrotic Syndrome Study Network
Ap rekriteEtid obsèvasyon
- Cleveland Clinic, Cleveland
NEPTUNE Match Study
Ap rekrite
- Cleveland Clinic Foundation, Cleveland
Etid Glomeruloskleroz fokal segmantè nan lòt vil
- Philadelphia, PA9 etid
- Durham, NC8 etid
- New York City, NY7 etid
- Ann Arbor, MI6 etid
- Queens, NY6 etid
- Miami, FL6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Atlanta, GA5 etid
- Chicago, IL4 etid
- Dallas, TX4 etid
- Kansas City, MO4 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.